Detalhe da pesquisa
1.
The risk factors and clinical outcomes in hepatitis B seropositive and seronegative renal transplant patients.
Am J Nephrol
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498992
2.
The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.
J Formos Med Assoc
; 122(7): 593-602, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456455
3.
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
Clin Infect Dis
; 75(3): 453-459, 2022 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864948
4.
Implementation and experience of an innovative smart patient care system: a cross-sectional study.
BMC Health Serv Res
; 22(1): 126, 2022 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093036
5.
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
Gastroenterology
; 154(4): 989-997, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174546
6.
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Gastroenterology
; 152(1): 134-141, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27639806
7.
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.
J Gastroenterol Hepatol
; 32(12): 1998-2005, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370350
8.
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.
Liver Int
; 36(8): 1101-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26835876
9.
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.
J Gastroenterol Hepatol
; 31(7): 1323-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26841930
10.
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.
Lancet
; 384(9954): 1597-605, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078304
11.
Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience.
Dig Dis Sci
; 59(7): 1603-16, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24482035
12.
Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular Carcinoma.
Clin Transl Gastroenterol
; 15(4): e00678, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240325
13.
Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.
J Chin Med Assoc
; 87(4): 357-368, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180018
14.
Conventional and machine-learning based risk score for patients with early-stage hepatocellular carcinoma.
Clin Mol Hepatol
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600872
15.
Increased incidence of orthopedic fractures in cirrhotic patients: a nationwide population-based study.
J Hepatol
; 58(4): 706-14, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23238105
16.
Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.
J Gastroenterol Hepatol
; 28(1): 112-21, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22849380
17.
Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response.
J Chin Med Assoc
; 86(9): 795-805, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466658
18.
The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B.
J Chin Med Assoc
; 86(10): 876-884, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537726
19.
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.
Ther Adv Med Oncol
; 14: 17588359221099401, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35646162
20.
Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis.
J Chin Med Assoc
; 85(2): 152-159, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759209